GTCBIO ANNOUNCES ITS 4th ANNUAL NEURODEGENERATIVE DISEASES DRUG DISCOVERY CONFERENCE ON OCTOBER 9-10, 2008 IN PHILADEPHIA, PA

Released on: August 7, 2008, 1:53 pm

Press Release Author: Dr. Ashraf Hanna

Industry:

Press Release Summary: August 7, 2008 - MONROVIA, CA - GTCbio just announced the
scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on
October 9-10, 2008 in Philadelphia, PA.

Press Release Body: August 7, 2008 - MONROVIA, CA - GTCbio just announced the
scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on
October 9-10, 2008 in Philadelphia, PA.

Neurodegenerative diseases continue to play an enormous role in the growing public
health problem, disrupting the quality of life of millions of people and costing
society billions of dollars annually.

Nonetheless, in the last few years, there has been great progress in the development
of novel therapeutic approaches to treat Alzheimer's, Parkinson's, Huntington's,
Multiple Sclerosis, Stroke and various other neurodegenerative diseases. There have
also been significant developments in our understanding of the genetics, the
molecular mechanisms and signaling pathways contributing to neuronal dysfunction,
neurotoxicity and pathology.

At the Neurodegenerative Diseases Drug Discovery forum, leading scientists and
experts will discuss these latest breakthroughs, new drug targets, new models, the
development of new biomarkers, imaging modalities, improved clinical trial designs
and several other novel developments and therapeutics to combat neurodegenerative
conditions.

Keynote presenters include Eric Karran, Chief Scientific Officer of the
Neurodegenerative Diseases Drug Hunting Team at Eli Lilly & Company and William Z.
Potter, Vice President of Translational Neuroscience at
Merck & Co.

For more information on attending, presenting a poster, or sponsoring, please visit
http://gtcbio.com/conferenceDetails.aspx?id=133.



Web Site: http://

Contact Details: GTCbio organizes conferences specifically for the biomedical and
biopharmaceutical industries. Our goal is to facilitate the exchange of
biopharmaceutical and biomedical intelligence between industry leaders, academic and
government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: Nina Tran, Senior Conference Producer, GTCbio (626) 256-6405, (626)
256-6460 fax, Nina.Tran@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •